Quarles & Brady has a long history of assisting clients with patents in the life sciences and biotechnology fields. As patent counsel to the Wisconsin Alumni Research Foundation (WARF), we wrote and obtained the broad-based patents on Dr. James Thomson’s groundbreaking research on primate and human embryonic stem cells. We continue to work not only in the stem cell field, but at the forefront of science to protect groundbreaking technologies. For example, our team manages an array of portfolios related to gene editing techniques and reagents, nanoparticles and biologics, among others, and their various applications in the life sciences and biology fields.
Our team includes attorneys, patent agents and technical specialists many of whom have advanced degrees and/or industry experience in areas such as immunology, microbiology, biochemistry, genetics, cell biology, molecular biology, and chemistry. We combine technical expertise with legal experience to represent a diverse array of clients. We have experience working with Fortune 500 companies, mid-sized and start-up companies, and research institutions to craft patent strategies to achieve the client's goals and objectives. We routinely collaborate with patent attorneys in numerous countries outside the United States to secure global patent protection.
Juristat ranked our team as a “2021 Top Patent Firm” in Technology Center 1600 at the USPTO. The Juristat ranking recognizes the firm’s extensive experience in life science industries, where it represents leading pharmaceutical and chemical companies, and renowned research institutions focused on novel health care, biotechnology and plant discoveries. The recognition was achieved based on our performance metrics in the categories of allowance rate, average office actions before allowance, and volume of applications filed. The life sciences team combines technical depth with client-focused service that is evidenced by this high Juristat ranking for Technology Center 1600.
Quarles & Brady has obtained hundreds of issued biotech patents for our clients. Our patent practice experience in the industry generally includes the following technology areas:
- Biologics including antibodies, aptamers and protein therapeutics
- Gene editing including CRISPR/Cas
- Immunology including cell-based therapies, vaccines and adjuvants
- Genetically engineered cells and organisms, including plants
- Diagnostics including genomic or proteomic markers
- Gene therapy including viral based therapeutics
- Drug delivery and therapeutics including therapeutic methods
- Biofuels and Biomass Processes
- Engineered Proteins including fusion proteins
- Plants including utility, plant patents and Plant Variety Protection